Establishment of an induced pluripotent stem cell line (FDEENTi001-A) from a patient with pathological myopia

Publication date: Available online 14 December 2018Source: Stem Cell ResearchAuthor(s): Xinyue Bai, Xianjie Yang, Yun Cheng, Ling ChenAbstractPathological myopia (PM) is a retinal degenerative disease with an increasing prevalence in Asia. The peripheral blood mononuclear cells (PBMCs) from a patient with PM were successfully reprogrammed to induced pluripotent stem cells (iPSCs) using integration-free method, Sendai viral (SeV) vectors expressing OCT4, SOX2, KLF4 and C-MYC. This line may provide a useful resource for exploring the pathogenesis of PM.
Source: Stem Cell Research - Category: Stem Cells Source Type: research